Fecal transplant may offer hope for pediatric UC

04/18/2013 | HealthDay News

Researchers at Helen DeVos Children's Hospital in Grand Rapids, Mich., said a clinical trial that included 10 ulcerative colitis patients, ages 7 to 20, showed fecal microbial transplantation led to a reduction in symptoms within a week for 78% of participants and elimination of symptoms in 33%. The trial, the first in the U.S. to evaluate fecal transplants in children, did not uncover any serious side effects from the procedure.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI